The Meta-Physics Of Meta-Analysis: US FDA’s Curious Framing Of New Safety Guidance
Executive Summary
Long delayed guidance on meta-analysis “will assist sponsors of drug and biological products in designing safety meta-analyses of randomized controlled trials using best practices,” FDA Commissioner says. True – but is that really the point?